BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34234555)

  • 21. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 22. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
    Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
    Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.
    Qi X; Liu Z; Zhang Q; Yang M; Wan Y; Huang J; Xu L
    J Cancer; 2021; 12(9):2537-2549. PubMed ID: 33854615
    [No Abstract]   [Full Text] [Related]  

  • 24. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma.
    Wang J
    Math Biosci Eng; 2021 Jun; 18(5):5125-5145. PubMed ID: 34517481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
    Front Oncol; 2020; 10():788. PubMed ID: 32528886
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and Biological Significance of DNA Methylation-Driven Differentially Expressed Genes in Biochemical Recurrence After Radical Prostatectomy.
    Luo C; He S; Zhang H; He S; Qi H; Wei A
    Front Genet; 2022; 13():727307. PubMed ID: 35186021
    [No Abstract]   [Full Text] [Related]  

  • 28. A gene signature driven by abnormally methylated DEGs was developed for TP53 wild-type ovarian cancer samples by integrative omics analysis of DNA methylation and gene expression data.
    Zhou Z; Jin H; Xu J
    Ann Transl Med; 2023 Jan; 11(1):20. PubMed ID: 36760264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma.
    Qu Y; Chen Y; Zhang L; Tian L
    World J Surg Oncol; 2020 Sep; 18(1):236. PubMed ID: 32883335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
    Ma JH; Huang Y; Liu LY; Feng Z
    J Int Med Res; 2021 May; 49(5):3000605211018443. PubMed ID: 34034542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a prognostic risk model of colorectal adenocarcinoma through integrated analysis of RNA-binding proteins.
    Liu X; Lv Q; Jing Z; Long X; Yi R; Yang D; Zhao X
    Transl Cancer Res; 2021 May; 10(5):1962-1974. PubMed ID: 35116519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
    DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
    Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
    Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.
    Ouyang G; Yi B; Pan G; Chen X
    Cancer Cell Int; 2020; 20():207. PubMed ID: 32514252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.
    Fang Z; Xu S; Xie Y; Yan W
    World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 13-gene risk score system and a nomogram survival model for predicting the prognosis of clear cell renal cell carcinoma.
    Zhang C; Wang F; Guo F; Ye C; Yang Y; Huang Y; Hou J; Tian F; Yang B
    Urol Oncol; 2020 Mar; 38(3):74.e1-74.e11. PubMed ID: 31952997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma.
    Fu X; Duanmu J; Li T; Jiang Q
    PeerJ; 2020; 8():e8877. PubMed ID: 32309045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.
    Wang X; Zhang D; Zhang C; Sun Y
    Ann Transl Med; 2020 Mar; 8(6):324. PubMed ID: 32355768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
    Tao C; Luo R; Song J; Zhang W; Ran L
    J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.